The IvyGene Core Test confirms the presence of multiple cancers, as early as stage 1. The Core Test has been validated for confirming the presence of breast, colon, liver, and lung cancer.
The IvyGene technology analyzes methylation ratios at specific gene targets in cell-free DNA. By identifying which gene targets are consistently hyper-methylated when cancer is present, the IvyGene technology is a highly accurate way to confirm the presence of cancer.
Only a medical provider may order the test. The test is performed through a simple blood draw [40mls]. Shipping is included in the wholesale price of the test. Results are returned within 5 business days.